Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley F Stein-Merlob

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiology Clinics|November 17, 2024
Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic AdvancesAshley F Stein-Merlob, Rachel Swier, Darko Vucicevic
Heart Failure Clinics|March 27, 2026
Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic AdvancesAshley F Stein-Merlob, Rachel Swier, Darko Vucicevic
Current Cardiology Reports|October 8, 2024
Inflammation in Chemotherapy-Induced CardiotoxicityElizabeth Hutchins, Eric H Yang, Ashley F Stein-Merlob
Heart Failure Clinics|June 19, 2022
T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager TherapiesAshley F Stein-Merlob, Sarju Ganatra, Eric H Yang
Current Cardiology Reports|January 23, 2021
Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and StrategiesAshley F Stein-Merlob, Michael V Rothberg, Patrick Holman, et al.
Heart (British Cardiac Society)|March 16, 2021
Cardiotoxicities of novel cancer immunotherapiesAshley F Stein-Merlob, Michael V Rothberg, Antoni Ribas, et al.
Frontiers in Cardiovascular Medicine|May 9, 2022
Novel Therapeutics for Anthracycline Induced CardiotoxicityJacqueline T Vuong, Ashley F Stein-Merlob, Richard K Cheng, et al.
Journal of the American Heart Association|November 26, 2025
Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and ManagementRachel S Saganty, Orly Leiva, Elizabeth Hutchins, et al.
Journal of the American College of Cardiology|February 11, 2022
Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art ReviewJacqueline T Vuong, Ashley F Stein-Merlob, Arash Nayeri, et al.
Circulation. Cardiovascular Imaging|May 11, 2017
Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular ImagingAshley F Stein-Merlob, Tetsuya Hara, Jason R McCarthy, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiology Clinics|November 17, 2024
Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic AdvancesAshley F Stein-Merlob, Rachel Swier, Darko Vucicevic
Heart Failure Clinics|March 27, 2026
Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic AdvancesAshley F Stein-Merlob, Rachel Swier, Darko Vucicevic
Current Cardiology Reports|October 8, 2024
Inflammation in Chemotherapy-Induced CardiotoxicityElizabeth Hutchins, Eric H Yang, Ashley F Stein-Merlob
Heart Failure Clinics|June 19, 2022
T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager TherapiesAshley F Stein-Merlob, Sarju Ganatra, Eric H Yang
Current Cardiology Reports|January 23, 2021
Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and StrategiesAshley F Stein-Merlob, Michael V Rothberg, Patrick Holman, et al.
Heart (British Cardiac Society)|March 16, 2021
Cardiotoxicities of novel cancer immunotherapiesAshley F Stein-Merlob, Michael V Rothberg, Antoni Ribas, et al.
Frontiers in Cardiovascular Medicine|May 9, 2022
Novel Therapeutics for Anthracycline Induced CardiotoxicityJacqueline T Vuong, Ashley F Stein-Merlob, Richard K Cheng, et al.
Journal of the American Heart Association|November 26, 2025
Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and ManagementRachel S Saganty, Orly Leiva, Elizabeth Hutchins, et al.
Journal of the American College of Cardiology|February 11, 2022
Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art ReviewJacqueline T Vuong, Ashley F Stein-Merlob, Arash Nayeri, et al.
Circulation. Cardiovascular Imaging|May 11, 2017
Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular ImagingAshley F Stein-Merlob, Tetsuya Hara, Jason R McCarthy, et al.
Pageof 2